Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601-003)
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase III study is to determine the safety and efficacy of difluprednate
in the management of inflammation following ocular surgery.